| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.52 | 0.0003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |